File S1 - Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells

Figure S1. Chemical structure of resveratrol. Figure S2. Differential cell response within the first 24 h after start of resveratrol treatment. Figure S3. No change of the acetylation status in Hep3B and HuH7 cells after resveratrol treatment. Figure S4. No resveratrol mediated hyperacetylation of histone protein H3 in Hep3B and HuH7 cells. Figure S5. Influence of SIRT1 activation by resveratrol in the HepG2 hepatoma cell context. Table S1. Calculated GoldScore values for resveratrol. Table S2. Calculated inhibitory concentrations (IC50) of resveratrol. (PDF)